显著地延长服用博特zomib的生存在初级治疗与对症终化点的重新定义

{"title":"显著地延长服用博特zomib的生存在初级治疗与对症终化点的重新定义","authors":"","doi":"10.1055/s-0030-1254861","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"33 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Signifikant längeres Überleben mit Bortezomib in der Primärtherapie und im Rezidiv - Neudefinitionen von Behandlungsendpunkten\",\"authors\":\"\",\"doi\":\"10.1055/s-0030-1254861\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":123656,\"journal\":{\"name\":\"Tumordiagn u Ther\",\"volume\":\"33 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tumordiagn u Ther\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0030-1254861\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumordiagn u Ther","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0030-1254861","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}